EGFR endocytosis is a novel therapeutic target in lung cancer with wild-type EGFR
作者： Ukhyun Jo , Kyong Hwa Park , Young Mi Whang , Jae Sook Sung , Nam Hee Won
关键词: Gefitinib 、 Pharmacology 、 In vivo 、 Lung cancer 、 Internal medicine 、 Viability assay 、 Epidermal growth factor receptor 、 Hematology 、 Medicine 、 Cancer research 、 Endocytosis 、 Kinase
摘要: … EGFR endocytosis and reverted the gefitinib response in gefitinib-sensitive lung cancer with … insight that EGFR endocytosis is a rational therapeutic target in lung cancer with wtEGFR, in …
elsevier.com
impactjournals.com参考文章(45)
Brian P. Ceresa, Regulation of EGFR endocytic trafficking by rab proteins. Histology and Histopathology. ,vol. 21, pp. 987- 993 ,(2006) , 10.14670/HH-21.987
Roy S. Herbst, Masahiro Fukuoka, José Baselga, Gefitinib — a novel targeted approach to treating cancer Nature Reviews Cancer. ,vol. 4, pp. 956- 965 ,(2004) , 10.1038/NRC1506
Christine Le Roy, Jeffrey L Wrana, None, Clathrin- and non-clathrin-mediated endocytic regulation of cell signalling Nature Reviews Molecular Cell Biology. ,vol. 6, pp. 112- 126 ,(2005) , 10.1038/NRM1571
Ming-Sound Tsao, Akira Sakurada, Jean-Claude Cutz, Chang-Qi Zhu, Suzanne Kamel-Reid, Jeremy Squire, Ian Lorimer, Tong Zhang, Ni Liu, Manijeh Daneshmand, Paula Marrano, Gilda da Cunha Santos, Alain Lagarde, Frank Richardson, Lesley Seymour, Marlo Whitehead, Keyue Ding, Joseph Pater, Frances A. Shepherd, Erlotinib in lung cancer - molecular and clinical predictors of outcome. The New England Journal of Medicine. ,vol. 353, pp. 133- 144 ,(2005) , 10.1056/NEJMOA050736
Daniel Kessler, Gianna-Carina Gruen, Dominik Heider, Jessica Morgner, Henning Reis, Kurt Werner Schmid, Verena Jendrossek, The action of small GTPases Rab11 and Rab25 in vesicle trafficking during cell migration. Cellular Physiology and Biochemistry. ,vol. 29, pp. 647- 656 ,(2012) , 10.1159/000295249
Y Ohsaki, S Tanno, Y Fujita, E Toyoshima, S Fujiuchi, Y Nishigaki, S Ishida, A Nagase, N Miyokawa, S Hirata, K Kikuchi, Epidermal growth factor receptor expression correlates with poor prognosis in non-small cell lung cancer patients with p53 overexpression. Oncology Reports. ,vol. 7, pp. 603- 610 ,(2000) , 10.3892/OR.7.3.603
William Pao, Vincent A. Miller, Epidermal Growth Factor Receptor Mutations, Small-Molecule Kinase Inhibitors, and Non–Small-Cell Lung Cancer: Current Knowledge and Future Directions Journal of Clinical Oncology. ,vol. 23, pp. 2556- 2568 ,(2005) , 10.1200/JCO.2005.07.799
Shawn M. Ferguson, Pietro De Camilli, Dynamin, a membrane-remodelling GTPase Nature Reviews Molecular Cell Biology. ,vol. 13, pp. 75- 88 ,(2012) , 10.1038/NRM3266
Brendan D. Manning, Lewis C. Cantley, AKT/PKB signaling: navigating downstream. Cell. ,vol. 129, pp. 1261- 1274 ,(2007) , 10.1016/J.CELL.2007.06.009
Federico Cappuzzo, Fred R. Hirsch, Elisa Rossi, Stefania Bartolini, Giovanni L. Ceresoli, Lynne Bemis, Jerry Haney, Samir Witta, Kathleen Danenberg, Irene Domenichini, Vienna Ludovini, Elisabetta Magrini, Vanesa Gregorc, Claudio Doglioni, Angelo Sidoni, Maurizio Tonato, Wilbur A. Franklin, Lucio Crino, Paul A. Bunn, Marileila Varella-Garcia, Epidermal Growth Factor Receptor Gene and Protein and Gefitinib Sensitivity in Non–Small-Cell Lung Cancer Journal of the National Cancer Institute. ,vol. 97, pp. 643- 655 ,(2005) , 10.1093/JNCI/DJI112